Pharmacopsychiatry is the study and the use of medications in treating psychiatric conditions. Psychiatric neuroscience and basic pharmacology are the foundation of pharmacopsychiatry. Clinical research in pharmacopsychiatry includes randomized clinical trials, observational studies, e.g., on drug safety, and meta-analyses on the efficacy of psychiatric drug treatments.
Pharmacopsychiatry also includes pharmacovigilance, pharmaco-genetics and therapeutic drug monitoring. The Section of Pharmacopsychiatry desires to reach a larger community of mental health experts to improve evidence-based psychiatry and safety of psychiatric treatments.
3rd Department of Psychiatry, Division of Neurosciences
School of Medicine, Aristotle University of Thessaloniki,
Mobile: +30 6945776935
University of Barcelona, CIBERSAM
Research Group Leader, Bipolar and Depressive Disorders, IDIBAPS
170 Villarroel st.
08036 Barcelona, Catalonia, Spain
Phone : +34932275477
Gregor Hasler, M.D.
Address: University of Fribourg
Chemin du Cardinal-Journet 3
Phone: +41 31 930 9974
>> Please click here to see the Section Members list